Bladder colloid carcinoma: A case report.

OA: gold
AI-generated summary by qwen3.7-flash, 2026-09-12

This case report describes a 72-year-old patient with bladder colloid carcinoma presenting as terminal hematuria, which was managed via transurethral resection and chemotherapy following the detection of pulmonary and bone metastases.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-08-22 · read from full text

This case report describes a 72-year-old male presenting with terminal hematuria who was diagnosed with primary colloid carcinoma of the bladder. Imaging and histological examination revealed an aggressive tumor with perivesical fat invasion, pulmonary metastasis, and bone lesions, leading to treatment with carboplatin-based chemotherapy. The patient died six months later due to multi-visceral failure, highlighting the poor prognosis associated with this rare malignancy. Relevance to endometriosis: endometriosis is cited in the discussion as a known risk factor for developing adenocarcinomas of the bladder, although the paper's main focus is on urologic oncology.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Non-urothelial bladder cancers are rare. We report the case of a 72-year-old who consulted for terminal hematuria evolving for three months. Computed Tomography scan showed a tumor of the anterior wall of the bladder. The patient underwent a transurethral resection of the bladder tumor. The histological examination of the tumor showed a bladder colloid carcinoma. The extension evaluation showed pulmonary and bone metastases. The patient received chemotherapy.
Full text 4,943 characters · extracted from pmc-nxml · 5 sections · click to expand

Case

A 72-year-old patient, diabetic, hypertensive, smoker, who consulted for terminal hematuria evolving for three months. There was no notion of professional exposure to aromatic amines or pelvic irradiation. He as haemodynamically stable. Physical examination was normal and no abdominal masses were palpable. The rectal examination was unremarkable. The hemoglobin level was 12.3 g/dl, and the creatinine level was 9.6 mg/L. The urine culture was negative. Prostate-specific-antigen level was at 2.3 ng/mL. Computed Tomography scan showed a tumor of the anterior wall of the bladder with the invasion of the perivesical fat ( Fig. 1 ). Cystoscopic exploration revealed a solid lesion in the anterior wall with a large base. The bladder neck was endoscopically normal. The patient underwent a complete and deep transurethral resection of the bladder tumor. The histological examination of the tumor showed a marked mucus production from the tumor, also noteworthy because mucous nodule formation occurs in more than 80% of tumor, the muscularis is invaded ( Fig. 2 ). As part of the extension work-up, a Computed Tomography scan showed a pulmonary metastasis ( Fig. 3 ) and multiple lytic bone lesions. The plasma level of carcinoembryonic antigen (CEA) was 0.9 ng/mL. Colonoscopy did not show any suspicious lesions. After a decision of multidisciplinary consultation meeting and discussion, the patient received carboplatin-based chemotherapy. After six months, the patient died with multi-visceral failure. Fig. 1 Computed Tomography scan showed a tumor of the anterior wall of the bladder with the invasion of the perivesical fat. Fig. 1 Fig. 2 The pathologic examination of the biopsy specimen showed abundant extracellular mucin with clusters of tumour cells floating in mucin lakes (hematoxylin-eosin x10). Fig. 2 Fig. 3 Computed Tomography scan showed a suspicious 14 mm lung nodule suggesting a metastatic location (arrow). Fig. 3 Computed Tomography scan showed a tumor of the anterior wall of the bladder with the invasion of the perivesical fat. The pathologic examination of the biopsy specimen showed abundant extracellular mucin with clusters of tumour cells floating in mucin lakes (hematoxylin-eosin x10). Computed Tomography scan showed a suspicious 14 mm lung nodule suggesting a metastatic location (arrow).

Conclusion

Non-urothelial bladder cancers particularly adenocarcinomas are rare but very aggressive with a poor prognosis studies should give more interest to this type of tumors so that clear recommendations for treatment and follow up can be established.

Discussion

Cases of adenocarcinomas of the bladder represent only 0.5–2% of all primary malignant bladder tumors. 2 The sex ratio is 2.7 men to one woman. 2 The risk factors are chronic S. haematobium infection, endometriosis, bladder enlargement and bladder exstrophy. 2 Adenocarcinomas are the third most frequent histological type of bladder tumors following urothelial carcinoma and squamous cell carcinoma. Primary bladder carcinomas always result from a glandular metaplasia of the urothelium caused by a chronic bladder irritation. 3 The dome of the bladder and the posterior wall are the two preferential sites of development of adenocarcinomas. 3 The primary colloid mucinous adenocarcinoma of the bladder also named signet-ring cell adenocarcinoma was firstly described in 1955 By Saphir. 4 It is a rare histologic type representing only 0.12–0.6% of all bladder cancers. 5 It is histologically defined by small, dissociated mucin-filled cytoplasmic vacuoles. For the differential diagnoses, we must eliminate a high-grade urothelial tumor, a metastasis or an urachal carcinoma by proceeding with gynecologic, gastroenterological and anatompathological examinations. It is the most aggressive type of adenocarcinomas, with a poor prognosis always discovered in an infiltrative or a metastatic form, 2 and commonly resistant to chemo and radiotherapy. 5 Because of its rarety there are no clear recommendations for the treatment of signet-ring cell adenocarcinoma of the bladder, 5 some publications suggested the partial cystectomy others suggested chemotherapy based on 5-fluorouracile (5-FU) but the results were not conclusive. The radical cystectomy with pelvic lymphnodes dissection can be proposed in the non-metastatic forms.

Introduction

Bladder cancer is the most frequent urologic cancer in tunisia and is the second in the world after prostatic cancer. Urothelial cancer is the most frequent type of bladder tumors. Non-urothelial bladder cancers are rare and only represent 5% of all genitourinary tract tumors. 1 Non-urothelial tumors affecting the bladder have generally an epithelial origin including: squamous cell carcinoma, adenocarcinoma, small cell carcinoma and undifferentiated carcinoma. 2 Non-urothelial bladder cancers have a poor prognosis and need a specific treatment and follow up.

Coi Statement

The authors declare that they have no competing interests.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-13T09:25:22.628771+00:00